X0609 4 2026-05-18 1 0001484565 SOLENO THERAPEUTICS INC SLNO 0001408502 Hahn Mark W false 100 MARINE PARKWAY, SUITE 400 REDWOOD CITY CA 94065 true false false false 0 Common Stock 2026-05-18 4 D 0 10046 D 0 D These shares are represented by previously reported restricted stock units ("RSUs"). Pursuant to the Agreement and Plan of Merger, dated as of April 5, 2026, by and among Soleno Therapeutics, Inc. (the "Company"), Neocrine Biosciences, Inc. ("Parent") and Sigma Merger Sub, Inc. ("Merger Sub"), on May 18, 2026, Merger Sub merged with and into the Company (the "Merger"), with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent. In connection with the Merger, each issued and outstanding vested and unvested RSU was cancelled and converted into the right to receive an amount equal to $53.00 in cash (the "Merger Consideration"). /s/ Anish Bhatnagar, Attorney-in-Fact 2026-05-18